Seer raises another $55M and finally reveals proteomic tech — can it hold up?

Jason Mast

Editor

Two years ago, Omid Farokhzad left his prominent nano-medicine lab at Boston’s Brigham and Women’s Hospital and moved across the country to found a startup …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Seer raises another $55M and finally reveals proteomic tech — can it hold up?

Jason Mast

Editor

Sign up to read this article for free.

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

Bluebird bio to sell to investment funds after struggling to make money from gene therapies

CBER's deputy director departs as staff shakeup continues

Eli Lilly stockpiles $548M of oral weight loss drug ahead of launch

Will CRISPR matter?

FDA says Ozempic, Wegovy shortage is over

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence

Seer rais­es an­oth­er $55M and fi­nal­ly re­veals pro­teom­ic tech — can it hold up?

Editor

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

Seer raises another $55M and finally reveals proteomic tech — can it hold up?